Bacterial peptides presented on tumour cells could be immunotherapy targets
Source: www.nature.com, March 2021
Human tumours are colonized by microorganisms, collectively called the tumour microbiota, that can affect the microenvironment of the tumour – for example, by causing inflammation or local immune suppression. This can lead to changes in how the body’s immune system responds to the tumour, and can alter responses to therapy.
